Revolution Medicines Inc To Acquire EQRx Inc Call Transcript
Good morning, everyone, and welcome to today's conference call. (Operator Instructions) Please note that today's conference call is being recorded.
I would now like to turn the call over to Erin Graves, Senior Director of Corporate Communications and Investor Relations at Revolution Medicines. Erin, please go ahead.
Thank you, operator. Good morning, everyone. Thank you for joining today's call to discuss Revolution Medicines' acquisitions of EQRx and other business updates. On today's call, Mark Goldsmith, Revolution Medicines' Chairman and Chief Executive Officer, will deliver his prepared remarks; and Jack Anders, Revolution Medicines' Chief Financial Officer; and Steve Kelsey, Revolution Medicines' President of Research and Development, will join Mark for the question-and-answer session.
Before we begin with the prepared remarks, we would like to remind you that Revolution Medicines and EQRx issued a joint press release, announcing the proposed acquisition earlier this morning. Revolution Medicines also published the corporate
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |